We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Goldman Sachs, JPMorgan, Citigroup, Evercore and Moelis
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 5, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Goldman Sachs (GS - Free Report) , JPMorgan (JPM - Free Report) , Citigroup (C - Free Report) , Evercore Inc. (EVR - Free Report) , Moelis Company (MC - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Resurgence of M&As and IPOs to Support Investment Banks
Global M&As were back with bang in the third quarter of 2020 as economic and business activities gradually resumed. During the quarter, dealmakers revisited transactions that were on hold as coronavirus wreaked havoc across the world.
Likewise, IPO activities rebounded, with the third quarter being one of the busiest since 2000. The green shoots of recovery were visible in the last couple of weeks of the second quarter in both M&As and IPOs, with trend witnessing a significant upswing during the third quarter.
Details
Per the data provided by Refinitiv, the quarter witnessed more than $1 trillion worth of M&As deals worldwide, mainly driven by strong performance in September. The majority of the transactions were in the coronavirus-resilient sectors like technology and healthcare.
Also, the third-quarter deal activity was up almost 80% sequentially. Specifically, the United States witnessed 75% jump in deal volume, while Asia and Europe recorded spike of 67% and 21%, respectively.
M&A deals worth $5 billion or more received a major boost, with more than 35 such transactions announced during the quarter.
Talking about IPO activities, the September quarter was mainly dominated by IPOs in healthcare (almost 50%), technology and blank-check companies. Data from Renaissance Capital shows that the total amount raised through IPOs was nearly $28.5 billion from 81 listings.
Road Ahead
Sustained economic recovery and the Federal Reserve’s efforts to provide sufficient liquidity to the economy are likely to support merger activities, going forward. Despite the U.S. presidential elections looming, companies are considering means to diversify business to weather the pandemic-induced slowdown.
Also, companies are largely using stock as a preferred acquisition mode, and preserving cash to tide over economic crises. Further, private equity firms, which were largely on the sidelines so far, have started deploying funds to make profitable investments.
Further, the pipeline for IPOs remains strong. Stacey Cunningham, president of the New York Stock Exchange in an interview to Bloomberg TV noted that after record September, October is also shaping up for a frenzy of listings. Airbnb Inc. and DoorDash Inc. are among the big names likely to debut in the coming months.
How Investment Banks Stand to Gain?
Though the coronavirus crisis adversely impacted the economy for much of 2020, gradual revival of businesses and support from the central bank have led to significant rise in capital market activities.
Investment banks, which provide underwriting and advisory services for IPOs and secondary market offerings along with M&As, are definitely going to benefit from the rise in these activities.
Thus, big names in the industry like Goldman Sachs along with those having significant exposure to investment banking activities including JPMorgan and Citigroup are expected to benefit from the resurgence of M&As and IPOs.
Additionally, smaller players like Evercore Inc., Moelis Company and Raymond James are likely to gain from the strong pipeline. Therefore, these companies are likely to witness a rise in both underwriting and advisory fees, going forward.
These Stocks are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Goldman Sachs, JPMorgan, Citigroup, Evercore and Moelis
For Immediate Release
Chicago, IL – October 5, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Goldman Sachs (GS - Free Report) , JPMorgan (JPM - Free Report) , Citigroup (C - Free Report) , Evercore Inc. (EVR - Free Report) , Moelis Company (MC - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Resurgence of M&As and IPOs to Support Investment Banks
Global M&As were back with bang in the third quarter of 2020 as economic and business activities gradually resumed. During the quarter, dealmakers revisited transactions that were on hold as coronavirus wreaked havoc across the world.
Likewise, IPO activities rebounded, with the third quarter being one of the busiest since 2000. The green shoots of recovery were visible in the last couple of weeks of the second quarter in both M&As and IPOs, with trend witnessing a significant upswing during the third quarter.
Details
Per the data provided by Refinitiv, the quarter witnessed more than $1 trillion worth of M&As deals worldwide, mainly driven by strong performance in September. The majority of the transactions were in the coronavirus-resilient sectors like technology and healthcare.
Also, the third-quarter deal activity was up almost 80% sequentially. Specifically, the United States witnessed 75% jump in deal volume, while Asia and Europe recorded spike of 67% and 21%, respectively.
M&A deals worth $5 billion or more received a major boost, with more than 35 such transactions announced during the quarter.
Talking about IPO activities, the September quarter was mainly dominated by IPOs in healthcare (almost 50%), technology and blank-check companies. Data from Renaissance Capital shows that the total amount raised through IPOs was nearly $28.5 billion from 81 listings.
Road Ahead
Sustained economic recovery and the Federal Reserve’s efforts to provide sufficient liquidity to the economy are likely to support merger activities, going forward. Despite the U.S. presidential elections looming, companies are considering means to diversify business to weather the pandemic-induced slowdown.
Also, companies are largely using stock as a preferred acquisition mode, and preserving cash to tide over economic crises. Further, private equity firms, which were largely on the sidelines so far, have started deploying funds to make profitable investments.
Further, the pipeline for IPOs remains strong. Stacey Cunningham, president of the New York Stock Exchange in an interview to Bloomberg TV noted that after record September, October is also shaping up for a frenzy of listings. Airbnb Inc. and DoorDash Inc. are among the big names likely to debut in the coming months.
How Investment Banks Stand to Gain?
Though the coronavirus crisis adversely impacted the economy for much of 2020, gradual revival of businesses and support from the central bank have led to significant rise in capital market activities.
Investment banks, which provide underwriting and advisory services for IPOs and secondary market offerings along with M&As, are definitely going to benefit from the rise in these activities.
Thus, big names in the industry like Goldman Sachs along with those having significant exposure to investment banking activities including JPMorgan and Citigroup are expected to benefit from the resurgence of M&As and IPOs.
Additionally, smaller players like Evercore Inc., Moelis Company and Raymond James are likely to gain from the strong pipeline. Therefore, these companies are likely to witness a rise in both underwriting and advisory fees, going forward.
These Stocks are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>
Join us on Facbook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.